TY - JOUR
T1 - Perineural dexamethasone added to peripheral nerve block in knee surgery
T2 - a systematic review with meta-analysis
AU - Viderman, Dmitriy
AU - Tapinova, Karina
AU - Aryngazin, Anuar
AU - Aubakirova, Mina
AU - Abdildin, Yerkin
N1 - Publisher Copyright:
© 2025 Termedia Publishing House Ltd.. All rights reserved.
PY - 2025
Y1 - 2025
N2 - The objective of the study was to assess the analgesic effects of dexamethasone (DEX) added to peripheral nerve block in knee surgery. We searched for relevant randomized controlled trials (RCTs) in PubMed and the Cochrane Database of Systematic Reviews. The latest search was done on September 11, 2024. Search terms included knee surgery, regional anesthesia, and DEX. Data extraction, statistical analysis, and risk of bias assessment followed established protocols. Seven RCTs with 551 patients were included. In the DEX 4 mg group, no reduction of pain at rest was found. However, for the DEX 8 mg group, pain management at rest was more effective; the mean difference (MD) with 95% CI was –0.34 [–0.50, –0.18]. For pain with movement, the model favors the DEX 4 mg group (MD with 95% CI was –1.03 [–1.84, –0.22]). Only one study reported the differences in pain intensity scores with movement between the DEX 8 mg and control groups. For morphine consumption, the model did not reveal any reduction in the DEX 4 mg group (MD –0.68 [–1.87, 0.5]) or DEX 8 mg group (MD –10.44 [–23.92, 3.03]). Pain with movement may be reduced with a lower dose, and pain without movement with a higher dose of DEX.
AB - The objective of the study was to assess the analgesic effects of dexamethasone (DEX) added to peripheral nerve block in knee surgery. We searched for relevant randomized controlled trials (RCTs) in PubMed and the Cochrane Database of Systematic Reviews. The latest search was done on September 11, 2024. Search terms included knee surgery, regional anesthesia, and DEX. Data extraction, statistical analysis, and risk of bias assessment followed established protocols. Seven RCTs with 551 patients were included. In the DEX 4 mg group, no reduction of pain at rest was found. However, for the DEX 8 mg group, pain management at rest was more effective; the mean difference (MD) with 95% CI was –0.34 [–0.50, –0.18]. For pain with movement, the model favors the DEX 4 mg group (MD with 95% CI was –1.03 [–1.84, –0.22]). Only one study reported the differences in pain intensity scores with movement between the DEX 8 mg and control groups. For morphine consumption, the model did not reveal any reduction in the DEX 4 mg group (MD –0.68 [–1.87, 0.5]) or DEX 8 mg group (MD –10.44 [–23.92, 3.03]). Pain with movement may be reduced with a lower dose, and pain without movement with a higher dose of DEX.
KW - adjuvant
KW - corticosteroids
KW - dexamethasone
KW - knee surgery
KW - morphine consumption
KW - pain intensity
KW - perineural
KW - peripheral nerve block
UR - http://www.scopus.com/inward/record.url?scp=105002822048&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105002822048&partnerID=8YFLogxK
U2 - 10.5114/ait/196700
DO - 10.5114/ait/196700
M3 - Review article
C2 - 40178317
AN - SCOPUS:105002822048
SN - 1642-5758
VL - 57
SP - 31
EP - 41
JO - Anaesthesiology Intensive Therapy
JF - Anaesthesiology Intensive Therapy
IS - 1
ER -